跳至主要内容
临床试验/NCT05761314
NCT05761314招募中不适用

Incidence and Molecular Pathogenesis of Solid Tumors in RASopathies

Fondazione Policlinico Universitario Agostino Gemelli IRCCS2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2021年10月12日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
2
主要终点
Prevalence of solid tumors in RASopathies

研究概览

简要总结

RASopathies are a group of syndromes, caused by variants of genes involved in the regulation of the Ras/MAP/ERK pathway. This intracellular transduction pathway profoundly affects embryogenic development, organogenesis, synaptic plasticity and neuronal growth.

RASopathies are characterized by multi-organ involvement, growth delay, premature aging and haemato-oncological manifestations.

Based on evidences provided by literature, cancer screening protocols are applied in some individuals affected by RASopathies, even though detailed information about prevalence and molecular pathogenesis of such tumors is still not clearly elucidate.

详细描述

To define the prevalence of solid (non-haematological) neoplasms in a monocentric cohort of patients affected by RASopathies To perform Next Generation Sequencing (NGS) analysis on tissue samples to preliminarily characterize the molecular pathogenesis of solid tumors in these patients' categories.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Clinical and molecularly confirmed diagnosis of a RASopathy

排除标准

  • Clinical diagnosis of RASopathy without molecular characterization

结局指标

主要结局

Prevalence of solid tumors in RASopathies

时间窗: 5 years

To detect prevalence of solid tumors in monocentric cohort of RASopathies

次要结局

  • Molecular characterization of solid tumors in RASopathies(5 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Solid Tumors in RASopathies | 临床试验